Key Record Dates
ClinicalTrials.gov Identifier: | NCT04315246 |
---|---|
Brief Title: | 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) |
First Submitted : | March 12, 2020 |
First Submitted that Met QC Criteria : | March 16, 2020 |
First Posted : | March 19, 2020 |
Last Update Submitted that Met QC Criteria : | July 12, 2022 |
Last Update Posted : | July 15, 2022 |